Trident Lifeline Ltd

Target overview

• Target: Trident Mediquip Limited, medical device company, incorporated Oct 19, 2019, based in Surat, India.
• Turnover: 27.31 Cr (FY25-26).
• Industry: Medical Device Industry.
• Subsidiary: subsidiary of Trident Lifeline Limited.
• Presence: India; registered office in Surat.

Shareholding and related party

• Related party: Trident Lifeline Limited owns Trident Mediquip Limited as subsidiary.
• Post-issue holding of TLL in TML: 58.23%; pre-holding: 59.67%.
• Private placement of equity shares to other shareholders.
• Promoter group has interest; arm's length transaction.

Target background and turnover history

• Date of incorporation: Oct 19, 2019.
• Presence: India.
• Recent turnover history: FY23-24 20.58 Cr; FY24-25 21.29 Cr; FY25-26 27.31 Cr.
• Line of business: Medical devices.

Regulatory and completion details

• Regulatory approvals: Not specified.
• Completion timeline: Not specified.
• Cost/consideration: Not disclosed.

Trident Lifeline Ltd — Trading Window closed from September 29, 2026; reopens 48 hours after the conclusion of the Board Meeting to consider the Un-Audited Financial Result for the Quarter and half year ended September 30, 2026.

Acquisition of Trident Mediquip

• Target: Trident Mediquip Limited, medical device company in India.
• Related party: TML is a subsidiary of Trident Lifeline; promoter group interests.
• Arm's length: transaction is at arm's length.
• Industry: Medical Device Industry.
• Consideration: cash of ₹95.40 lakhs.
• Pre-acq holding: 58.67%; Post-acq holding: 59.67%.
• Turnover FY2023-24: ₹20.58 cr.
• Turnover FY2024-25: ₹21.29 cr.
• Turnover FY2025-26: ₹27.31 cr.
• Incorporation: 19 Oct 2019; registered in Surat, Gujarat.
• Presence: India.
• Regulatory approvals: NA.
• Purpose: increase stake in subsidiary and consolidate control.
• Completion timeline: not specified.

Meeting Details

• Date: October 05, 2026; via video conferencing at the registered office.

Key Agenda Items

• Consider proposal to raise funds via warrants/equity/convertible securities and appoint intermediaries.
• Consider and fix date/time/place of Extraordinary General Meeting and approve notice.

Other Notes

• Trading window closed from Sep 29, 2026 until 48 hours after the meeting, i.e., Oct 7, 2026.

AGM details

• AGM held on 26 September 2026 from 04:00 PM to 04:17 PM via VC/OAVM.
• Voting entitlement cut-off date: 19 September 2026.

Resolutions

• Resolution 1: Adopt standalone and consolidated financial statements (Ordinary).
• Resolution 2: Re-appoint director by rotation (Ordinary).
• Resolution 3: Approve related party transactions for FY 2026-27 (Ordinary).
• Resolution 4: Approve remuneration in excess of statutory limits (Special).
• Resolution 5: Waiver of excess managerial remuneration (Special).

Voting results

• Resolution 1 passed; 7,482,890 in favour, 0 against; 62.71% of votes polled.
• Resolution 2 passed; 7,482,890 in favour, 0 against; 100% of valid votes.
• Resolution 3 passed; 559,200 in favour, 0 against.
• Resolution 4 passed; 559,200 in favour, 0 against.
• Resolution 5 passed; 559,200 in favour, 0 against.

Dividend

• Dividend: Not proposed or declared.

Directors & auditors

• Director changes: Re-appointment of Hardik Jigishkumar Desai (rotating director).
• Auditors: No change disclosed in this filing.

Material related party transactions

• Related party transactions approved for FY 2026-27; counterparties not disclosed.

Other material approvals

• Remuneration in excess of limits approved; waiver of excess remuneration approved.

Meeting Details

• Date and time: 28 September 2026, 12:30 p.m.–5:30 p.m.
• Type/Mode: one-on-one plant visit (physical)
• Venue: Surat
• Arranged by: NeoAtlas Capital Advisory LLP

Participants

• Key company participants: Company Secretary and Compliance Officer
• Key company participants: Investor Relations contact

Purpose

• Purpose: investor/analyst plant visit with Stylus Holdings

Additional Notes

• Recording/transcript not indicated

AGM Details

• Date, time, mode: 26 Sep 2026, 04:00 PM, VC/OAVM.

Key Resolutions

• Ordinary: Adopt standalone and consolidated financial statements for FY2026.
• Ordinary: Re-appoint Hardik Jigishkumar Desai by rotation.
• Special: Approve related party transactions for FY2026-27.
• Special: Approve managerial remuneration exceeding statutory limits.
• Special: Waiver of excess remuneration to Ashish Anandsingh Bafna.

Voting Status

• Voting results not disclosed in the excerpt; final results to be filed with exchanges within 48 hours.

Director Changes

• Re-appointment of Hardik Jigishkumar Desai by rotation approved (per ordinary business).

Related Party Transactions

• Approval of related party transactions for FY2026-27.

Remuneration Approvals

• Remuneration in excess of statutory limits approved.

Remuneration Waiver

• Waiver of excess remuneration paid to Ashish Anandsingh Bafna.

Meeting Details

• Date and time: October 1, 2026, 10:00 a.m. to 6:00 p.m.
• Type/Mode: Group meeting; Plant Visit (physical) at Vapi and Surat.
• Organiser: NeoAtlas Capital Advisory LLP (Atlas Capital) arranged the visit.
• Purpose: Plant visit for investors and analysts to observe operations.
• Company participants: Company Secretary and Compliance Officer of Trident Lifeline Ltd.

Share price movement clarification

• All material disclosures per SEBI Listing Regulations have been made.
• Share price movement is market-driven; no pending information affecting price.